Open-angle glaucoma is linked to an increased risk for early-onset Alzheimer’s disease in middle-aged adults, especially men, ...

Glaucoma often progresses without symptoms until vision loss is permanent. Experts outline seven early warning signs and ...

Regardless of whether it is a swept-source or spectral-domain platform, OCT angiography is comparably useful for monitoring ...

Omidenepag isopropyl led to significant IOP reductions that were sustained over the course of 5 years in patients with ...

Their conversation focuses on anatomy-driven, individualized approaches and multidisciplinary decision-making for patients ...

Sight Sciences, Inc. (Nasdaq: SGHT) (Sight Sciences or the Company), an eyecare technology company focused on developing and commercializing innovative ...

Shares of Glaukos retreated after the company forecast disappointing sequential revenue growth for its iDose product in the fourth quarter. The stock declined 12% to $97 in after-hours trading on ...

Five hundred people in the Canadian province of New Brunswick were diagnosed with a "mystery brain disorder" that resembled prion disease; a 2025 study offered explanations, but some patients rejected ...

What Is Driving the New Fair Value Estimate for Sight Sciences? Sight Sciences now carries a fair value estimate of US$9.35 ...

Higher fat-to-muscle ratios in the legs are strongly protective against POAG, while other regional fat mass is associated with higher IOP.

ViaLase Inc. announced that the first patient has been treated in an investigational device exemption (IDE) clinical trial ...